RxDoctor Payments Data

Patricia Pagnotta

Adult Health · Maitland, FLNPI 1316048200

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $275,669 of the $409,253 with a category attached, or 67.4%. 60 manufacturers reported payments, led by EMD Serono, Inc. at 30.8% of the total. Among adult health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$409,253in general payments, 2019–2025

Across 1,830 payments — averaging $223.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$126K
  • AstraZeneca$64K
  • E.r. Squibb & Sons, L.L.C.$45K
  • Biogen$45K
  • Sanofi$38K
  • TG Therapeutics, Inc.$32K
  • plus $59K from 54 others
$31,350in research payments, 2019–2025

Across 7 payments — averaging $4478.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • TG Therapeutics, Inc.$31K
  • Sanofi$100

What the payments were for

  • Consulting fees$46,78911%
  • Speaking & faculty fees$275,66967%
  • Travel & lodging$50,16412%
  • Food & beverage$36,0989%
  • Education$5350%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.240$125,985
AstraZeneca148$63,980
E.r. Squibb & Sons, L.L.C.71$44,800
Biogen152$44,774
Sanofi84$38,045
TG Therapeutics, Inc.67$32,131
Bristol Myers Squibb65$12,045
Johnson & Johnson24$7,114
Mallinckrodt Hospital Products Inc.31$6,925
Amgen(2 entities)47$6,446
Genentech USA, Inc.89$6,159
Teva Pharmaceuticals USA, Inc.38$3,838
Merck Kgaa2$3,290
Neurocrine Biosciences, Inc.150$2,855
AbbVie(2 entities)149$2,274
Novartis124$890
UCB, Inc.32$718
Lundbeck LLC20$536
Lilly USA, LLC28$471
Eisai Inc.15$412
Argenx US, Inc.20$366
Supernus Pharmaceuticals, Inc.17$358
Pfizer16$326
Jazz Pharmaceuticals Inc.12$293
CSL Behring10$254
Tanabe Pharma America, Inc.12$224
Biohaven Pharmaceuticals, Inc.8$219
Scilex Pharmaceuticals Inc.12$219
Amneal Pharmaceuticals LLC14$219
Takeda Pharmaceuticals U.S.A., Inc.8$207
Otsuka America Pharmaceutical, Inc.9$192
GE HealthCare8$189
SK Life Science, Inc.7$188
Genentech, Inc.2$177
Sandoz2$164
Alnylam Pharmaceuticals Inc.6$151
Neurelis, Inc.8$146
Banner Life Sciences, LLC6$146
Catalyst Pharmaceuticals, Inc.5$144
Biohaven Pharmaceutical Holding Company Ltd.6$121
Sunovion Pharmaceuticals Inc.7$120
Grifols USA, LLC6$115
Acadia Pharmaceuticals Inc6$92
Upsher-smith Laboratories LLC4$85
Harmony Biosciences LLC3$72
Vanda Pharmaceuticals Inc.3$66
Xeris Pharmaceuticals, Inc.3$65
Kyowa Kirin, Inc.3$65
Sumitomo Pharma America, Inc.3$58
Acorda Therapeutics, Inc3$57
Avadel CNS Pharmaceuticals, LLC2$57
Averitas Pharma Inc.2$53
Livanova USA, Inc.3$52
Arbor Pharmaceuticals, Inc.4$51
Merz Pharmaceuticals, LLC1$26
Impel Pharmaceuticals Inc.1$23
Avanir Pharmaceuticals, Inc.1$23
Cala Health, Inc.1$21
Avion Pharmaceuticals1$20
Merck1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$409,253 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Kesimpta PenOfatumumab11$113,563

Paid to pharmacies, not to this prescriber.

Other adult health in Maitland

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →